Overview

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the safety, tolerability and pharmacokinetics of inhaled CHF 6001 after single and multiple doses in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.